Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1017.00x is 42% above its 5-year average of -1743.41x, near the high end of its 5-year range (-5692.33x–-3.88x).
As of the fiscal period ended Tuesday, December 31, 2024. 66.03% above its 12-month average of -2993.75x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2024 (2024-12-31): -1017.00x.
INTEREST COVERAGE RATIO
-1017.00x
INTEREST COVERAGE RATIO AVG TTM
-2993.75x
INTEREST COVERAGE RATIO AVG 3Y
-1653.05x
INTEREST COVERAGE RATIO AVG 5Y
-1743.41x
INTEREST COVERAGE RATIO AVG 10Y
-860.53x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+66.03%
CURRENT VS 3Y AVG
+38.48%
CURRENT VS 5Y AVG
+41.67%
CURRENT VS 10Y AVG
-18.18%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.45x
median of 435 covered companies
CURRENT VS SECTOR MEDIAN
-18560.55%
vs the sector median at left
Mustang Bio, Inc.
Market Cap
$3.49M
Interest Coverage Ratio
-1017.00x
TTM Avg
-2993.75x
3Y Avg
-1653.05x
5Y Avg
-1743.41x
Market Cap
$3.45M
Interest Coverage Ratio
-0.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.55M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.34M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.32M
Interest Coverage Ratio
-507.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.28M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.25M
Interest Coverage Ratio
-12.86x
TTM Avg
85.32x
3Y Avg
145.98x
5Y Avg
123.76x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | $3.49M | -1017.00x | -2993.75x | -1653.05x | -1743.41x |
| Moolec Science S.A. (MLEC)vs › | $3.45M | -0.25x | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.55M | N/A | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.42M | -7.42x | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.42M | N/A | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.34M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.32M | -507.49x | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.28M | N/A | N/A | N/A | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | -12.86x | 85.32x | 145.98x | 123.76x |
| MBody AI Ltd. (MBAI)vs › | $3.17M | -12.83x | N/A | N/A | N/A |
Interest Coverage
-1017.0x
Debt/Equity
0.00
Current Ratio
1.97
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-12-31 | -1017.00x |
| 2024-09-30 | -1457.00x |
| 2024-06-30 | -4270.00x |
| 2024-03-31 | -5231.00x |
| 2023-09-30 | -2576.75x |
| 2023-06-30 | -101.39x |
| 2023-03-31 | -13.88x |
| 2022-12-31 | -16.75x |
| 2022-09-30 | -18.23x |
| 2022-06-30 | -19.51x |
| 2022-03-31 | -85.38x |
| 2021-12-31 | -5029.75x |
| 2021-09-30 | -5692.33x |
| 2021-06-30 | -3610.00x |
| 2021-03-31 | -3771.75x |
| 2020-12-31 | -1885.27x |
| 2020-09-30 | -3.88x |
| 2020-06-30 | -22.81x |
| 2020-03-31 | -19.20x |
| 2019-12-31 | -26.36x |
| 2019-09-30 | -17.29x |
| 2019-06-30 | -17.79x |
| 2019-03-31 | -886.73x |
| 2018-12-31 | -1487.50x |
| 2017-12-31 | -1966.13x |
| 2017-03-31 | -1653.00x |
| 2016-12-31 | 19.29x |
| 2016-09-30 | -8.27x |
| 2016-06-30 | 11.18x |
| 2016-03-31 | -10.15x |
| 2015-12-31 | -12.40x |
| 2015-09-30 | -11.34x |
